IFA Reduces Risk of Stunting - Study from Nepal (January 2016)

The study investigated the effect of antenatal iron-folic acid (IFA) supplementation on child stunting in Nepalese children age <2 years. A retrospective pooled cohort of 5235 most recent live births from 2001, 2006 and 2011 Nepal Demographic and Health Surveys was analyzed. The adjusted relative risk of being stunted was 14% lower in children whose mothers consumed IFA supplements compared to those whose mothers did not consume IFA. The greatest impact on reducing the risk of child stunting was when IFA supplementation was initiated ≤6 months and when  ≥90 supplements consumed during pregnancy, with a 23% reduction in risk of stunting (aRR = 0.77, 95% CI = 0.64-0.92).